Quantcast

Latest ankylosing spondylitis Stories

2009-10-06 10:14:00

HORSHAM, Pa. and KENILWORTH, N.J., Oct. 6 /PRNewswire/ -- Centocor Ortho Biotech Inc. and Schering-Plough Corporation (NYSE: SGP) announced today that the European Commission has approved SIMPONI(TM) (golimumab) as a once-monthly, subcutaneous therapy for the treatment of moderate-to-severe, active rheumatoid arthritis (RA), active and progressive psoriatic arthritis (PsA) and severe, active ankylosing spondylitis (AS). In the European Union, SIMPONI is approved as a 50 mg subcutaneous...

2009-07-21 19:30:18

Chinese patients will soon have the opportunity to take part in a study of a novel therapy aimed at reversing the autoimmune disease, ankylosing spondylitis. Approximately 200 patients will be chosen to participate in a clinical trial that aims to merge the latest molecular discoveries published by the California non-profit Autoimmunity Research Foundation (ARF) with the medical expertise of physicians and researchers at West China Hospital.Located at Sichuan University, West China Hospital...

2009-07-01 18:58:13

The risk of tuberculosis for patients who take arthritis drugs differs from that of the French population at large depending on the agent used, researchers say. Treatment with anti-tumor necrosis factor agents is recognized as a risk factor for TB in patients with immune-mediated inflammatory diseases such as rheumatoid arthritis, ankylosing spondylitis, Crohn's disease, psoriatic arthritis and psoriasis. Xavier Mariette of the Universite Paris-Sud says most TB cases develop as a result of...

2009-06-26 04:00:00

Positive Opinion Recommends Approval of New Anti-TNF Therapy in Three Rheumatic Diseases with Novel SmartJect(TM) Autoinjector HORSHAM, Pa. and KENILWORTH, N.J., June 26 /PRNewswire-FirstCall/ -- Centocor Ortho Biotech Inc. and Schering-Plough Corporation (NYSE: SGP) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) adopted a positive opinion recommending the approval of SIMPONI(TM) (golimumab) as a once-monthly,...

2009-06-25 15:13:55

Health Canada is warning consumers not to use the prescription drug piroxicam to treat short-term pain and inflammation because of safety risks. The federal agency said it has conducted a safety review of the drug and concluded piroxicam causes an increased risk of serious skin reactions and gastrointestinal problems. Piroxicam is a prescription drug in the family known as non-selective non-steroidal anti-inflammatory drugs. Federal officials said they determined the risks associated with its...

2009-06-16 09:15:45

A new study by The George Institute for International Health has found Tai Chi to have positive health benefits for musculoskeletal pain. The results of the first comprehensive analysis of Tai Chi suggest that it produces positive effects for improving pain and disability among arthritis sufferers.The researchers are now embarking on a new trial to establish if similar benefits can be seen among people with chronic low back pain."This is the first robust evidence to support the beneficial...

2009-06-15 12:34:08

The beneficial effects of pregnancy and childbearing on arthritic conditions may be more long-term than previously thought, Norwegian researchers said. Dr. Marianne Wallenius, of the Norwegian University of Science and Technology, said nulliparous women -- those who have not given birth to children -- are diagnosed with chronic arthritides -- including ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis an average of 5.2 years before parous women -- who have given birth to...

2009-06-12 11:07:38

 After five years of receiving infliximab (IFX) anti-TNF therapy, 61.8% of patients with ankylosing spondylitis (AS) showed substantial clinical benefit (ASAS40, ASsessment in AS, 40-response) and 27.6% achieved ASAS partial remission.Moreover, at five years, 78.4% of AS patients had no arthritis and 84.9% had no enthesitis (inflammation at the junction between tendon and bone). Over this period, patients continued to show a sustained high response rate, low disease activity, good...

2009-06-11 10:26:10

New study suggests the beneficial effects of pregnancy and childbearing on arthritic conditions may be more long-term than previously understoodNulliparous women (those who have not given birth to children) are diagnosed with chronic arthritides (including ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis (RA) an average of 5.2 years before parous women (those who have given birth to children), according to a new study presented today at EULAR 2009, the Annual Congress of...

2009-06-09 17:01:00

Long-Term Data in Patients Receiving Every-Four-Week Subcutaneous SIMPONI Presented at 2009 EULAR Annual Congress COPENHAGEN, June 9 /PRNewswire/ -- Findings from open-labeled, uncontrolled extensions of two randomized, placebo-controlled Phase 3 studies showed that subcutaneous (SC) injections of SIMPONI(TM) (golimumab) 50 mg or 100 mg every four weeks provided persistent improvements in the signs and symptoms in patients with psoriatic arthritis (PsA) and ankylosing spondylitis (AS)....


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related